Agenda

Gregory W. Mattingly, MD
David Goodman, MD
Joel L. Young MD

1 Additional hour of CME credit

Click here to claim credit

Supported an Independent Educational Grant from Supernus

ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live event for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

For Pharmacists
Medscape designates this continuing education activity for 1.0 contact hour(s) (0.100 CEUs) (Universal Activity Number: JA0007105-0000-22-140-L01-P).

This program provides an overview of pivotal trial data on efficacy and safety profile of an adjunctive therapy for adult patients with major depressive disorder (MDD)

This is a NON-CME/CE Presentation. 

Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck

©2022 Otsuka America Pharmaceutical, Inc. All rights reserved.

June 2022       11US22EBP0110

SESSION CHAIR: Henry A. Nasrallah, MD

1:00 PM CT | Novel Approaches in Schizophrenia Treatment
Christoph U. Correll, MD

1:30 PM CT | Addressing Treatment-Resistant Schizophrenia: Best Practices in Assessment and Management
Jonathan Meyer, MD

2:00 PM CT | Q & A
Christoph U. Correll, MD
Jonathan Meyer, MD
Moderator: Henry A. Nasrallah, MD

Supported by an independent educational grant from Alkermes, Inc.
Supported by an independent educational grant from Cerevel Therapeutics

ACCREDITATION STATEMENT: SESSION I
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 3.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours in the area of pharmacology.

SESSION CHAIR: Donald W. Black, MD

3:00 PM CT | Welcome
Donald W. Black, MD

3:05 PM CT | When the System Is Down: Post-COVID Impact on Societal Mental Health
Kiki D. Chang, MD

3:25 PM CT | The Future of Practice Is Virtual
Jay Shore, MD, MPH

3:45 PM CT | Battling Burnout: Understanding Mental Health and Suicidality Amoung HCPs
Sidney Zisook, MD

4:05 PM CT | Expanding Mental Health Care: The Role of Non-Physician Practitioners
Amanda J. Simonton, PhD, APRN, PMHNP-BC

4:25 PM CT | Q & A
Donald W. Black, MD
Kiki D. Chang, MD
Jay Shore, MD, MPH
Sidney Zisook, MD
Amanda J. Simonton, PhD, APRN, PMHNP-BC
Moderator: Donald W. Black, MD, Moderator

Supported by an independent educational grant from Supernus Pharmaceuticals, Inc.
Supported by an independent educational grant from Alkermes, Inc.
Supported by an independent educational grant from Cerevel Therapeutics
Supported by an independent educational grant from Corium, Inc.

ACCREDITATION STATEMENT: SESSION II
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours in the area of pharmacology.

In an effort to build awareness of the mental health crisis facing children, adolescents and young adults in the US, the filmmakers of the upcoming documentary titled Hiding in Plain Sight: Youth Mental Illness will be joined by a patient featured in the film to discuss the background of the film and the importance of sharing this information with the public.

Speakers:

Ken Burns, Executive Producer *pre-recorded
Maclayn Clark, Patient
Mary Clark, Mother
Christopher Loren Ewers, Co-Director and Director of Photography
Erik Ewers, Co-Director and Editor

About the Film:
Longtime WETA production partner Ken Burns is the executive producer of a major new public television documentary, Hiding in Plain Sight: Youth Mental Illness. The film, premiering in June 2022, gives voice to the experiences of young people who struggle with mental health challenges and focuses on the importance of awareness and empathy. Premieres June 27 & 28 9/8c on PBS.

The documentary will shine a clear —and sometimes stark —light on what it is like for youth as well as for the parents, teachers, friends and healthcare providers who try to help. Just as society has rallied around people with cancer and efforts for a cure, it is time to rally around children and adolescents who suffer mental health disorders —to see it as our common struggle, not somebody else’s problem. The first in a three-film series from the Ewers brothers on mental health.

Erik Ewers and Christopher Loren Ewers are the co-directors, Julie Coffman is the producer, and David Blistein is the writer. The four-hour film is part of the Well Beings Youth Mental Health Project.

ACCREDITATION STATEMENT: KEYNOTE
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours in the area of pharmacology.

SESSION CHAIR: Gregory W. Mattingly, MD

10:25 AM CT | Welcome
Gregory W. Mattingly, MD

10:30 AM CT | Innovations in ADHD: Pharmacologic and Nonpharmacologic Advancements
Gregory W. Mattingly, MD

11:00 AM CT | Case Conundrums in ADHD: Managing Comorbid Psychiatric Disorders
Ann C. Childress, MD

11:30 AM CT | Supporting Patients Through the Transition to Independence
Margaret H. Sibley, PhD

12:00 PM CT | Q & A
Ann C. Childress, MD
Margaret H. Sibley, PhD
Moderator: Gregory W. Mattingly, MD

Supported by an independent educational grant from Supernus Pharmaceuticals, Inc.
Supported by an independent educational grant from Akili Interactive Labs, Inc.
Supported by an independent educational grant from Corium, Inc.

ACCREDITATION STATEMENT: SESSION IV
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours in the area of pharmacology.

This program will provide an overview of the clinical data, information for use in clinical practice, and important safety information supporting an oral treatment option for adult patients living with schizophrenia or bipolar I disorder.

Sponsored by Alkermes, Inc. 

This is a NON-CME/CE Presentation.

SESSION CHAIR: Gregory W. Mattingly, MD

2:30 PM CT | Welcome
Gregory W. Mattingly, MD

2:35 PM CT | Don't Miss the Diagnosis: Differentiating Bipolar Depression
Leslie Citrome, MD, MPH

3:05 PM CT | Bipolar Spectrum Disorders: Individualizing Treatment and Updates in Advancements
Holly A. Swartz, MD

3:35 PM CT | Q & A
Leslie Citrome, MD, MPH
Holly A. Swartz, MD
Moderator: Gregory W. Mattingly, MD

Supported by an independent educational grant from Alkermes, Inc.

ACCREDITATION STATEMENT: SESSION V
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.5 contact hours in the area of pharmacology.

SESSION CHAIR: Sanjay Gupta, MD

4:10 PM CT | Welcome
Sanjay Gupta, MD

4:15 PM CT | Breaking Down Barriers to Mental Health Care for Minority Communities
Napoleon B. Higgins, Jr, MD

4:45 PM CT | Approaching LGBTQ Mental Health Status and Care: Are We Narrowing the Gap?
Petros Levounis, MD, MA

5:15 PM CT | Q & A
Napoleon B. Higgins, Jr, MD
Petros Levounis, MD, MA
Moderator: Sanjay Gupta, MD

Supported by an independent educational grant from Supernus Pharmaceuticals, Inc.
Supported by an independent educational grant from Alkermes, Inc.
Supported by an independent educational grant from Cerevel Therapeutics
Supported by an independent educational grant from Corium, Inc.
Supported by an independent educational grant from Pear Therapeutics, Inc.

ACCREDITATION STATEMENT: SESSION VI
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

For Physicians
Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses
Awarded 1.5 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours in the area of pharmacology.